Literature DB >> 22678321

Minimally invasive treatment of gastric gastrointestinal stromal tumors: laparoscopic and endoscopic approach.

In Ho Jeong1, Ji Hun Kim, Sang Rim Lee, Jin Hong Kim, Jae Chul Hwang, Sung Jae Shin, Kee Myung Lee, Hoon Hur, Sang Uk Han.   

Abstract

PURPOSE: This study aimed to verify the long-term outcome of a minimally invasive endoscopic or laparoscopic approach for the treatment of gastric gastrointestinal stromal tumor (GIST).
METHODS: This single-center study involved a retrospective review of gastric tumors that were pathologically confirmed as GIST. A total of 84 patients who underwent minimally invasive endoscopic or laparoscopic resection for gastric GIST were enrolled from February 2002 to June 2007. These demographics, tumor characteristics, and outcomes were analyzed for identification of outcomes and feasibility of endoscopic or laparoscopic resection.
RESULTS: Of 84 patients, 27 and 57 patients underwent endoscopic and laparoscopic resection, respectively. The average tumor size was 3.1 ± 1.7 cm. With a mean follow-up of 40.5 ± 20.7 months, 82 (97.7%) patients were disease free. Two patients, both of whom underwent laparoscopic resection, were alive with peritoneal recurrence. Two (7.4%) and 6 (10.5%) patients, respectively, had postoperative complications after endoscopic resection and laparoscopic resection. There was no significant difference in the operative morbidity according to tumor size. There was no postoperative mortality.
CONCLUSIONS: Laparoscopic surgery for gastric GIST is safe and feasible, even in large (>5 cm) tumors. Because endoscopic resection showed good results without recurrence, this approach can be useful in selected cases with a high operative risk or a need for preservation of organ function.

Entities:  

Mesh:

Year:  2012        PMID: 22678321     DOI: 10.1097/SLE.0b013e31825078f2

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  24 in total

1.  Microscopic positive tumor margin does not increase the rate of recurrence in endoscopic resected gastric mesenchymal tumors compared to negative tumor margin.

Authors:  Yan Zhu; Mei-Dong Xu; Chen Xu; Xiao-Cen Zhang; Shi-Yao Chen; Yun-Shi Zhong; Yi-Qun Zhang; Wei-Feng Chen; Tian-Yin Chen; Jia-Xin Xu; Li-Qing Yao; Quan-Lin Li; Ping-Hong Zhou
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

2.  Long-term outcomes of combined endoscopic/laparoscopic intragastric enucleation of presumed gastric stromal tumors.

Authors:  Jeffrey S Mino; Alfredo D Guerron; Rosebel Monteiro; Kevin El-Hayek; Jeffrey L Ponsky; Deepa T Patil; R Matthew Walsh
Journal:  Surg Endosc       Date:  2015-08-15       Impact factor: 4.584

3.  A modified endoscopic method for resection of gastric submucosal tumor.

Authors:  Qiang Zhang; Yue Li; Zhou-Yang Lian; Zhen Wang; Li-Hui Wang; Yang Bai; Si-de Liu
Journal:  Surg Endosc       Date:  2017-06-29       Impact factor: 4.584

4.  Endoscopic resection of gastric gastrointestinal stromal tumors originating from the muscularis propria layer in North America: methods and feasibility data.

Authors:  Iman Andalib; Daniel Yeoun; Ramesh Reddy; Steve Xie; Shahzad Iqbal
Journal:  Surg Endosc       Date:  2017-09-15       Impact factor: 4.584

5.  Diagnosis and surgical treatment of esophageal gastrointestinal stromal tumors.

Authors:  Fang-Biao Zhang; Hong-Can Shi; Yu-Sheng Shu; Wei-Ping Shi; Shi-Chun Lu; Xiang-Yan Zhang; Shao-Song Tu
Journal:  World J Gastroenterol       Date:  2015-05-14       Impact factor: 5.742

Review 6.  Lap-Endo cooperative surgery (LECS) in gastric GIST: updates and future advances.

Authors:  Thomas Zheng Jie Teng; Farhan Ishraq; Amelia Fang Ting Chay; Kon Voi Tay
Journal:  Surg Endosc       Date:  2022-10-11       Impact factor: 3.453

7.  Laparoscopic-endoscopic cooperative surgery for gastric submucosal tumors.

Authors:  Wei-Ming Kang; Jian-Chun Yu; Zhi-Qiang Ma; Zi-Ran Zhao; Qing-Bin Meng; Xin Ye
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

8.  Prognositic factors and clinicopathologic characteristics of small gastrointestinal stromal tumor of the stomach: a retrospective analysis of 31 cases in one center.

Authors:  Zhen Huang; Yuan Li; Hong Zhao; Jian-Jun Zhao; Jian-Qiang Cai
Journal:  Cancer Biol Med       Date:  2013-09       Impact factor: 4.248

9.  Gastrointestinal stromal tumor mesenchymal neoplasms: the offspring that choose the wrong path.

Authors:  Nikolaos Machairiotis; Ioanna Kougioumtzi; Paul Zarogoulidis; Aikaterini Stylianaki; Konstantinos Tsimogiannis; Nikolaos Katsikogiannis
Journal:  J Multidiscip Healthc       Date:  2013-03-31

10.  Non-Hodgkin lymphoma and GIST: molecular pathways and clinical expressions.

Authors:  Michael Karanikas; Nikolaos Machairiotis; Paul Zarogoulidis; Aikaterini Stylianaki; Nikolaos Corcoutsakis; Alexandros Mitrakas; Panagiotis Touzopoulos; Nikolaos Lyratzopoulos; George Kouklakis; Manolis Spanoudakis; Alexandros Polychronidis
Journal:  Onco Targets Ther       Date:  2012-12-12       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.